Depression

Comorbid SUD Reduces Likelihood of Optimal Depression Care
Patients with depression are less likely to receive guideline-concordant outpatient depression treatment if they have co-occurring substance use disorder, researchers found in a study published online in The American Journal of Psychiatry.
Psychedelic Treatment Dramatically Reduces Depression Symptoms in Study
Doses of psilocybin, provided in combination with supporting psychotherapy, was found to produce significant reductions in symptoms of major depression in a study conducted by researchers at Johns Hopkins University.
Depression Diagnosis in Teens Linked With Declining Educational Performance
Students diagnosed with depression undergo a drop in educational performance around ages 15 and 16 years, and boys and students from deprived backgrounds may be especially vulnerable, a study shows.
Excessive Use of Social Media During COVID-19 Outbreak Predicted Depression
While social media was rewarding to many users looking for informational, emotional, and peer support when the COVID-19 pandemic hit, excessive use led to mental health issues, according to a study published in Computers in Human Behavior.
Zuranolone Improves Depressive Symptoms Within 14 Days
Zuranolone, an investigational neuroactive steroid, improved depressive symptoms in a majority of patients within a 14-day treatment course, topline results from an ongoing phase 3 open-label study show.
Psychedelics Bring Patients Face-to-Face with Underlying Issues
The use of psychedelics in psychotherapy can help patients go beyond ameliorating symptoms and confront their root causes of depression, Andrew D. Penn, RN, MS, NP, CNS, APRN-BC, and Charles Raison, MD, said at a session at the Psych Congress 2020…
Adjunctive Brexpiprazole Enhances Calming, Engagement in MDD
Patients with major depressive disorder (MDD) reported feeling calmer and more engaged after treatment with adjunctive brexpiprazole, according to a poster presented at Psych Congress 2020.
Daily Social Media Use Does Not Raise Depression Risk in Teens
Daily social media use is neither a strong nor consistent risk factor for depressive symptoms in adolescents in the United States, according to a new study published in the Journal of Adolescent Health.
Using Inflammatory Biomarkers to Guide Depression Treatment Choices
Psych Congress 2020 cochair Charles Raison, MD, discusses the role of inflammatory biomarkers in guiding depression treatment choices.
Combining Ketamine With Psychotherapy to Treat Depression
A session being presented at Psych Congress 2020 will educate attendees on the practice of combining ketamine treatment with psychotherapy for patients with treatment-resistant depression (TRD).
Dr. Michael Thase Answers Your Questions on Depression Treatments
Michael E. Thase, MD, spoke at the 2020 Psych Congress Elevate conference on adjunctive and combination therapies for difficult-to-treat depression. Here, he answers some of the questions asked by attendees.

Audio

Dr. Rakesh Jain Gives an Update on Glutamate
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, speaks with general psychiatrist Abbey Strauss, MD, MSW, about the history, chemistry, and potential use of the neurotransmitter…
Back to Top